Bausch + Lomb Corp trades with the ticker BLCO on the TSX and is in the Medical Instruments & Supplies industry.
Overview
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products for therapeutic use, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, dry eye, and redness relief. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.
Looking to invest in Bausch + Lomb Corp? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
BLCO.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $7753.413MM
PE Ratio:
Price: 16.4 (Updated: 3/12/2024 0:47:16)
Bausch + Lomb Corp (BLCO) vs Competitors in Medical Instruments & Supplies
Lets see how BLCO.TO stacks up against others in the Medical Instruments & Supplies asset management industry. We have identified its main peers as:CRH Medical Corporation, Opsens Inc
.Medical Instruments & Supplies Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| CRH Medical Corporation (CRH) | $357.386 | N/A | 36.599 | 0.0% |
| Opsens Inc (OPS) | $335.469 | N/A | -35.119 | 0.0% |
| Bausch + Lomb Corp (BLCO) | $7,753.413 | N/A | 26.946 | N/A% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Medical Instruments & Supplies
- Bausch + Lomb Corp (BLCO) vs CRH Medical Corporation (CRH)
- CRH has higher EPS (0.024 vs -1.0). CRH provides dividends, while BLCO does not. CRH and BLCO both have P/E’s under 0.
- Bausch + Lomb Corp (BLCO) vs Opsens Inc (OPS)
- OPS has higher EPS (-0.11 vs -1.0). OPS provides dividends, while BLCO does not. OPS and BLCO both have P/E’s under 0.
Our Recommendation: Review
May not stand out on key metrics or lacks sufficient data for a strong recommendation.
How to Buy BLCO stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
